MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Balance Sheets Overview
Current Ratio
3.84%
Quick Ratio
3.84%
Cash Ratio
2.08%
Debt to Asset Ratio
507.02%
Unit: Dollar
Assets Breakdown
Due from subsidiaries
Intangible assets, net (note 6)
Cash and cash equivalents
Others
Liabilities Breakdown
Accumulated deficit
Additional paid in capital
Accounts payable
Others
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Balance Sheets
2026-06-30
2026-03-31
2025-09-30
2025-06-30
Cash and cash equivalents
83,586
23,145
91,995
10,062
Loan receivable
60,095
60,095
-
-
Prepaid expenses
10,600
6,100
20,800
10,150
Total current assets
154,281
89,340
112,795
20,212
Intangible assets, net (note 6)
158,898
105,542
-
-
Due from subsidiaries
478,571
377,814
-
-
Intangible assets, net (note 6)
-
-
118,577
125,094
Total other assets
637,469
483,356
-
-
Total assets
791,750
572,696
231,372
145,306
Accounts payable
1,729,921
1,592,882
1,209,667
1,124,065
Convertible notes payable (note 8)
725,138
500,549
532,081
290,811
Loan payable - related parties (note 7)
802,972
744,420
700,383
631,891
Loan payable (note 8)
756,285
550,000
90,000
90,000
Total current liabilities
4,014,316
3,387,851
2,532,131
2,136,767
Total liabilities
4,014,316
3,387,851
2,532,131
2,136,767
Preferred stock, 0.001 par value, 20,000,000 shares authorized 11,300,000 and 11,300,000 common shares issued and outstanding respectively (note 9)
11,300
11,300
11,300
11,300
Preferred stock series a, 0.001 par value, 5,000 shares authorized 3,050 and 3,050 shares issued and outstanding, respectively (note 9)
15,250
15,250
15,250
15,250
Common stock, 0.001 par value, 500,000,000 shares authorized 153,916,565 and 153,211,252 common shares issued and outstanding respectively (note 9)
153,917
153,212
137,830
137,512
Additional paid in capital
3,017,027
2,873,102
2,593,976
2,450,576
Accumulated deficit
-6,420,060
-5,868,019
-5,059,115
-4,606,099
Total stockholders deficit
-3,222,566
-2,815,155
-2,300,759
-1,991,461
Total liabilities and stockholders deficit
791,750
572,696
231,372
145,306
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Balance Sheets
Due from
subsidiaries
$478,571
Intangible assets, net
(note 6)
$158,898
(27.02%↑ Y/Y)
Cash and cash
equivalents
$83,586
(730.71%↑ Y/Y)
Loan receivable
$60,095
Prepaid expenses
$10,600
(4.43%↑ Y/Y)
Total other assets
$637,469
Total current assets
$154,281
(663.31%↑ Y/Y)
Total assets
$791,750
(444.88%↑ Y/Y)
Accumulated deficit
-$6,420,060
(-39.38%↓ Y/Y)
Total liabilities and
stockholders deficit
$791,750
(444.88%↑ Y/Y)
Total stockholders
deficit
-$3,222,566
(-61.82%↓ Y/Y)
Additional paid in capital
$3,017,027
(23.12%↑ Y/Y)
Common stock, 0.001 par
value, 500,000,000...
$153,917
(11.93%↑ Y/Y)
Preferred stock series a,
0.001 par value, 5,000...
$15,250
(0.00%↑ Y/Y)
Preferred stock, 0.001 par
value, 20,000,000...
$11,300
(0.00%↑ Y/Y)
Total liabilities
$4,014,316
(87.87%↑ Y/Y)
Total current
liabilities
$4,014,316
(87.87%↑ Y/Y)
Accounts payable
$1,729,921
(53.90%↑ Y/Y)
Loan payable -
related parties (note 7)
$802,972
(27.07%↑ Y/Y)
Loan payable (note 8)
$756,285
(740.32%↑ Y/Y)
Convertible notes payable
(note 8)
$725,138
(149.35%↑ Y/Y)
Buy us a coffee
AVAI BIO, INC. (AVAI)
AVAI BIO, INC. (AVAI)